Navigation Links
Recently FDA-Approved Full Neck Treatment for Sagging Skin Now Available at Maryland Laser Skin and Vein Institute
Date:12/28/2012

Baltimore, MD (PRWEB) December 28, 2012

Ultherapy non-surgical ultrasound treatments, which the physicians at the Maryland Laser, Skin and Vein Institute have been using for facial treatments, are now FDA-cleared for use to treat sagging skin on the neck and under the chin.

In a single treatment session, Ultherapy can tighten lax neck skin and improve firmness, all without any downtime. The Ulthera device uses sound waves targeted beneath the skin to gently heat, tighten and lift the skin, creating a younger, firmer look. And because Ulthera uses ultrasound, the surface skin is left undisturbed.

"We are excited to extend the range of Ultherapy treatments we offer to our patients for use on the neck,” says Dr. Weiss. “We’ve been having great results with Ulthera already on the face and already seeing improvements from application on the neck."

Based in Hunt Valley (Baltimore), MD, the MDLSV Institute not only treats thousands of patients per year, but is a leading clinical research facility investigating new skin treatments and devices for the purposes of FDA clearance and improving patient treatments and outcomes.

To schedule a consultation for treatment with Board Certified Dermatologists, please contact MDLSV (http://www.mdlsv.com)

Dr. Weiss, Director of the Maryland Laser Skin and Vein Institute, is one of America’s foremost dermatologists, and a past president of the American Society of Dermatologic Surgery. As an authority on dermatology, cosmetic dermatology and dermatologic surgery, laser medicine, and non-invasive body contouring, Dr. Weiss
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
2. Stemedica Issued U.S. Patent For Stem Cell Treatment of Diabetic Retinopathy and Diabetic Optic Neuropathy
3. Mold Linked With Fatal Asthma and Allergy Attacks; Dr Mold Network Suggests Use of Molderizer and Safe Shield for Safer Mold Treatment
4. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
5. CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments
6. Sandy Mold Extends Its Health Risks to Hired Cleaners; My Cleaning Products Says Complete Mold Treatment Gear and Molderizer are Needed to Stop Mold and Its Risks
7. NKT Therapeutics Presents Data on Potential Antibody Treatment for Sickle Cell Disease
8. A Sewage Treatment Plant Goes Underground Using In-Pipe Technology Company, Inc. Bioaugmentation
9. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
10. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
11. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... NY (PRWEB) June 18, 2013 In ... and sustainability, the Consulate General of Switzerland in New ... boat, Switzerland’s MS Tûranor PlanetSolar , to Manhattan. ... of its DeepWater Expedition 2013 tour with scientists on ... by Capitain Gérard d’Aboville, runs exclusively on energy from ...
(Date:6/18/2013)... Demanding industrial and environmental conditions are no ... and Glass Ball Lenses, now available in an extensive ... , of Philadelphia , PA. , Optical Ball Lenses ... beams without the need for direct physical contact. That’s ... mohs) make it the ideal choice for fiber-optic applications ...
(Date:6/18/2013)... AZ (PRWEB) June 18, 2013 Nasseo, ... 2013 Innovation Challenge Winner out of hundreds of applicants ... its spring Arizona Innovation Challenge . The Arizona ... country for a technology commercialization challenge, granting a financial ... most promising technology ventures. Nasseo’s state of the art ...
(Date:6/18/2013)... ATLANTA , June 18, 2013  regulated information ... Jeff Klauk today announced the launch of ... their loved ones. The Pledge ... take a stand and make a personal commitment to ... with their health care team and additional partial-onset seizure ...
Breaking Biology Technology:Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6
... Calif., Jan. 12 WaferGen Biosystems,Inc. (OTC ... state-of-the-art gene,expression, genotyping, cell biology and stem ... have successfully demonstrated the,performance of the company,s ... of the platform,s ongoing alpha testing program. ...
... -- Simcere Pharmaceutical Group,(NYSE: SCR ), ... and manufacturer of the patented anti-cancer biotech product,Endu ... preliminary revenue,and earnings for the full year of ... preliminary data for the fourth quarter, Simcere expects ...
... PHOENIX, Jan. 9 Houlihan Smith & Co., ... non-control equity investment,into Sottera, Inc. d/b/a NJOY, as ... Chairman of Houlihan Smith & Company, Inc. ... Reginald McGaugh.,Terms were not disclosed. , ...
Cached Biology Technology:WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 2WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 3WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 4WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 5Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings 2Houlihan Smith Arranges Non-Control Equity Investment Into Sottera, Inc., dba NJOY, by Miri Pharma, Inc. 2
(Date:6/19/2013)... In fall 2012, the European Medicines Agency (EMA) ... the first ever gene therapy for clinical use ... company, had developed AAV-LPL S447X for the treatment ... lipase deficiency (LPLD) which affects approximately one or ... causes severe, life-threatening inflammations of the pancreas. Afflicted ...
(Date:6/18/2013)...  Paris Air Show – Marvin Test ... a leading provider of innovative test solutions for ... solutions this week at the Paris Air ... including increasingly complex armament systems with longer lifecycles, ... test solutions that address legacy system obsolescence. Marvin ...
(Date:6/18/2013)... Energy Department,s National Renewable Energy Laboratory (NREL), and ... paper describing a novel cellulose-degrading enzyme from a ... known as the gribble. , Gribbles are ... ability to produce their own enzymes instead of ... they eat. New biomass-degrading enzymes from novel sources ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3Novel enzyme from tiny gribble could prove a boon for biofuels research 2
... Austin-based startup cofounded by Mauro Ferrari, Ph.D., of The ... to improve the effectiveness of anti-cancer agents and other ... through the Texas Emerging Technology Fund (ETF). NMS ... awards, which were announced by Texas Gov. Rick Perry ...
... -- The body,s immune system hates strangers. When its ... This is the problem when people with type ... cells from a donor pancreas produce robust amounts of ... insulin therapy. However, the immune system tries to kill ...
... of birth, mouse ovaries are essentially a bag full ... This key time in ovarian development establishes the population ... cohort of follicles. If follicles fail to form, the ... for follicular development. Several factors key to follicular formation ...
Cached Biology News:Texas invests record $3.5 million in startup cofounded by UT's Mauro Ferrari 2New technique eliminates toxic drugs in islet transplant in diabetic mice 2December 2008 highlights from Biology of Reproduction 2